- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
As the global economy mends, the 2021 growth of Onychomycosis (Tinea Unguium) Drug will have significant change from previous year. According to our latest study, the global Onychomycosis (Tinea Unguium) Drug market size is USD million in 2022 from USD 3216.5 million in 2021, with a change of % between 2021 and 2022. The global Onychomycosis (Tinea Unguium) Drug market size will reach USD 4841.8 million in 2028, growing at a CAGR of 6.0% over the analysis period.
The United States Onychomycosis (Tinea Unguium) Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Onychomycosis (Tinea Unguium) Drug market, reaching US$ million by the year 2028. As for the Europe Onychomycosis (Tinea Unguium) Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Onychomycosis (Tinea Unguium) Drug players cover Pfizer, Yangtze River, Torrent Pharma, and J&J, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Onychomycosis (Tinea Unguium) Drug market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Oral Medication
External Medicine
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Age under 18
Age 18-50
Age above 50
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Pfizer
Yangtze River
Torrent Pharma
J&J
Chengdu Brilliant
Novartis
Qilu Pharmaceutical
Xiuzheng Pharmaceutical
Hubei Hengan
TARO
Perrigo
Galderma pharm
Zhejiang Deyer
Valeant Pharma
Moberg
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Onychomycosis (Tinea Unguium) Drug Market Size 2017-2028
2.1.2 Onychomycosis (Tinea Unguium) Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Onychomycosis (Tinea Unguium) Drug Segment by Type
2.2.1 Oral Medication
2.2.2 External Medicine
2.3 Onychomycosis (Tinea Unguium) Drug Market Size by Type
2.3.1 Onychomycosis (Tinea Unguium) Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Type (2017-2022)
2.4 Onychomycosis (Tinea Unguium) Drug Segment by Application
2.4.1 Age under 18
2.4.2 Age 18-50
2.4.3 Age above 50
2.5 Onychomycosis (Tinea Unguium) Drug Market Size by Application
2.5.1 Onychomycosis (Tinea Unguium) Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Application (2017-2022)
3 Onychomycosis (Tinea Unguium) Drug Market Size by Player
3.1 Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Players
3.1.1 Global Onychomycosis (Tinea Unguium) Drug Revenue by Players (2020-2022)
3.1.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Players (2020-2022)
3.2 Global Onychomycosis (Tinea Unguium) Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Onychomycosis (Tinea Unguium) Drug by Regions
4.1 Onychomycosis (Tinea Unguium) Drug Market Size by Regions (2017-2022)
4.2 Americas Onychomycosis (Tinea Unguium) Drug Market Size Growth (2017-2022)
4.3 APAC Onychomycosis (Tinea Unguium) Drug Market Size Growth (2017-2022)
4.4 Europe Onychomycosis (Tinea Unguium) Drug Market Size Growth (2017-2022)
4.5 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size Growth (2017-2022)
5 Americas
5.1 Americas Onychomycosis (Tinea Unguium) Drug Market Size by Country (2017-2022)
5.2 Americas Onychomycosis (Tinea Unguium) Drug Market Size by Type (2017-2022)
5.3 Americas Onychomycosis (Tinea Unguium) Drug Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Onychomycosis (Tinea Unguium) Drug Market Size by Region (2017-2022)
6.2 APAC Onychomycosis (Tinea Unguium) Drug Market Size by Type (2017-2022)
6.3 APAC Onychomycosis (Tinea Unguium) Drug Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Onychomycosis (Tinea Unguium) Drug by Country (2017-2022)
7.2 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Type (2017-2022)
7.3 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Onychomycosis (Tinea Unguium) Drug by Region (2017-2022)
8.2 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Type (2017-2022)
8.3 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Onychomycosis (Tinea Unguium) Drug Market Forecast
10.1 Global Onychomycosis (Tinea Unguium) Drug Forecast by Regions (2023-2028)
10.1.1 Global Onychomycosis (Tinea Unguium) Drug Forecast by Regions (2023-2028)
10.1.2 Americas Onychomycosis (Tinea Unguium) Drug Forecast
10.1.3 APAC Onychomycosis (Tinea Unguium) Drug Forecast
10.1.4 Europe Onychomycosis (Tinea Unguium) Drug Forecast
10.1.5 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Forecast
10.2 Americas Onychomycosis (Tinea Unguium) Drug Forecast by Country (2023-2028)
10.2.1 United States Onychomycosis (Tinea Unguium) Drug Market Forecast
10.2.2 Canada Onychomycosis (Tinea Unguium) Drug Market Forecast
10.2.3 Mexico Onychomycosis (Tinea Unguium) Drug Market Forecast
10.2.4 Brazil Onychomycosis (Tinea Unguium) Drug Market Forecast
10.3 APAC Onychomycosis (Tinea Unguium) Drug Forecast by Region (2023-2028)
10.3.1 China Onychomycosis (Tinea Unguium) Drug Market Forecast
10.3.2 Japan Onychomycosis (Tinea Unguium) Drug Market Forecast
10.3.3 Korea Onychomycosis (Tinea Unguium) Drug Market Forecast
10.3.4 Southeast Asia Onychomycosis (Tinea Unguium) Drug Market Forecast
10.3.5 India Onychomycosis (Tinea Unguium) Drug Market Forecast
10.3.6 Australia Onychomycosis (Tinea Unguium) Drug Market Forecast
10.4 Europe Onychomycosis (Tinea Unguium) Drug Forecast by Country (2023-2028)
10.4.1 Germany Onychomycosis (Tinea Unguium) Drug Market Forecast
10.4.2 France Onychomycosis (Tinea Unguium) Drug Market Forecast
10.4.3 UK Onychomycosis (Tinea Unguium) Drug Market Forecast
10.4.4 Italy Onychomycosis (Tinea Unguium) Drug Market Forecast
10.4.5 Russia Onychomycosis (Tinea Unguium) Drug Market Forecast
10.5 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Forecast by Region (2023-2028)
10.5.1 Egypt Onychomycosis (Tinea Unguium) Drug Market Forecast
10.5.2 South Africa Onychomycosis (Tinea Unguium) Drug Market Forecast
10.5.3 Israel Onychomycosis (Tinea Unguium) Drug Market Forecast
10.5.4 Turkey Onychomycosis (Tinea Unguium) Drug Market Forecast
10.5.5 GCC Countries Onychomycosis (Tinea Unguium) Drug Market Forecast
10.6 Global Onychomycosis (Tinea Unguium) Drug Forecast by Type (2023-2028)
10.7 Global Onychomycosis (Tinea Unguium) Drug Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Onychomycosis (Tinea Unguium) Drug Product Offered
11.1.3 Pfizer Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Yangtze River
11.2.1 Yangtze River Company Information
11.2.2 Yangtze River Onychomycosis (Tinea Unguium) Drug Product Offered
11.2.3 Yangtze River Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Yangtze River Main Business Overview
11.2.5 Yangtze River Latest Developments
11.3 Torrent Pharma
11.3.1 Torrent Pharma Company Information
11.3.2 Torrent Pharma Onychomycosis (Tinea Unguium) Drug Product Offered
11.3.3 Torrent Pharma Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Torrent Pharma Main Business Overview
11.3.5 Torrent Pharma Latest Developments
11.4 J&J
11.4.1 J&J Company Information
11.4.2 J&J Onychomycosis (Tinea Unguium) Drug Product Offered
11.4.3 J&J Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 J&J Main Business Overview
11.4.5 J&J Latest Developments
11.5 Chengdu Brilliant
11.5.1 Chengdu Brilliant Company Information
11.5.2 Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Product Offered
11.5.3 Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Chengdu Brilliant Main Business Overview
11.5.5 Chengdu Brilliant Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Onychomycosis (Tinea Unguium) Drug Product Offered
11.6.3 Novartis Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Qilu Pharmaceutical
11.7.1 Qilu Pharmaceutical Company Information
11.7.2 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Offered
11.7.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Qilu Pharmaceutical Main Business Overview
11.7.5 Qilu Pharmaceutical Latest Developments
11.8 Xiuzheng Pharmaceutical
11.8.1 Xiuzheng Pharmaceutical Company Information
11.8.2 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Offered
11.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Xiuzheng Pharmaceutical Main Business Overview
11.8.5 Xiuzheng Pharmaceutical Latest Developments
11.9 Hubei Hengan
11.9.1 Hubei Hengan Company Information
11.9.2 Hubei Hengan Onychomycosis (Tinea Unguium) Drug Product Offered
11.9.3 Hubei Hengan Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Hubei Hengan Main Business Overview
11.9.5 Hubei Hengan Latest Developments
11.10 TARO
11.10.1 TARO Company Information
11.10.2 TARO Onychomycosis (Tinea Unguium) Drug Product Offered
11.10.3 TARO Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 TARO Main Business Overview
11.10.5 TARO Latest Developments
11. Perrigo
11.11.1 Perrigo Company Information
11.11.2 Perrigo Onychomycosis (Tinea Unguium) Drug Product Offered
11.11.3 Perrigo Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Perrigo Main Business Overview
11.11.5 Perrigo Latest Developments
11.12 Galderma pharm
11.12.1 Galderma pharm Company Information
11.12.2 Galderma pharm Onychomycosis (Tinea Unguium) Drug Product Offered
11.12.3 Galderma pharm Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Galderma pharm Main Business Overview
11.12.5 Galderma pharm Latest Developments
11.13 Zhejiang Deyer
11.13.1 Zhejiang Deyer Company Information
11.13.2 Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Product Offered
11.13.3 Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Zhejiang Deyer Main Business Overview
11.13.5 Zhejiang Deyer Latest Developments
11.14 Valeant Pharma
11.14.1 Valeant Pharma Company Information
11.14.2 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product Offered
11.14.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Valeant Pharma Main Business Overview
11.14.5 Valeant Pharma Latest Developments
11.15 Moberg
11.15.1 Moberg Company Information
11.15.2 Moberg Onychomycosis (Tinea Unguium) Drug Product Offered
11.15.3 Moberg Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Moberg Main Business Overview
11.15.5 Moberg Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Onychomycosis (Tinea Unguium) Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Oral Medication
Table 3. Major Players of External Medicine
Table 4. Onychomycosis (Tinea Unguium) Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Onychomycosis (Tinea Unguium) Drug Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Type (2017-2022)
Table 7. Onychomycosis (Tinea Unguium) Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Onychomycosis (Tinea Unguium) Drug Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Application (2017-2022)
Table 10. Global Onychomycosis (Tinea Unguium) Drug Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Player (2020-2022)
Table 12. Onychomycosis (Tinea Unguium) Drug Key Players Head office and Products Offered
Table 13. Onychomycosis (Tinea Unguium) Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Onychomycosis (Tinea Unguium) Drug Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Regions (2017-2022)
Table 18. Americas Onychomycosis (Tinea Unguium) Drug Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Country (2017-2022)
Table 20. Americas Onychomycosis (Tinea Unguium) Drug Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Type (2017-2022)
Table 22. Americas Onychomycosis (Tinea Unguium) Drug Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Application (2017-2022)
Table 24. APAC Onychomycosis (Tinea Unguium) Drug Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Region (2017-2022)
Table 26. APAC Onychomycosis (Tinea Unguium) Drug Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Type (2017-2022)
Table 28. APAC Onychomycosis (Tinea Unguium) Drug Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Application (2017-2022)
Table 30. Europe Onychomycosis (Tinea Unguium) Drug Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Country (2017-2022)
Table 32. Europe Onychomycosis (Tinea Unguium) Drug Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Type (2017-2022)
Table 34. Europe Onychomycosis (Tinea Unguium) Drug Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Onychomycosis (Tinea Unguium) Drug
Table 43. Key Market Challenges & Risks of Onychomycosis (Tinea Unguium) Drug
Table 44. Key Industry Trends of Onychomycosis (Tinea Unguium) Drug
Table 45. Global Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Onychomycosis (Tinea Unguium) Drug Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Onychomycosis (Tinea Unguium) Drug Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Onychomycosis (Tinea Unguium) Drug Market Size Market Share Forecast by Application (2023-2028)
Table 51. Pfizer Details, Company Type, Onychomycosis (Tinea Unguium) Drug Area Served and Its Competitors
Table 52. Pfizer Onychomycosis (Tinea Unguium) Drug Product Offered
Table 53. Pfizer Onychomycosis (Tinea Unguium) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Pfizer Main Business
Table 55. Pfizer Latest Developments
Table 56. Yangtze River Details, Company Type, Onychomycosis (Tinea Unguium) Drug Area Served and Its Competitors
Table 57. Yangtze River Onychomycosis (Tinea Unguium) Drug Product Offered
Table 58. Yangtze River Main Business
Table 59. Yangtze River Onychomycosis (Tinea Unguium) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Yangtze River Latest Developments
Table 61. Torrent Pharma Details, Company Type, Onychomycosis (Tinea Unguium) Drug Area Served and Its Competitors
Table 62. Torrent Pharma Onychomycosis (Tinea Unguium) Drug Product Offered
Table 63. Torrent Pharma Main Business
Table 64. Torrent Pharma Onychomycosis (Tinea Unguium) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Torrent Pharma Latest Developments
Table 66. J&J Details, Company Type, Onychomycosis (Tinea Unguium) Drug Area Served and Its Competitors
Table 67. J&J Onychomycosis (Tinea Unguium) Drug Product Offered
Table 68. J&J Main Business
Table 69. J&J Onychomycosis (Tinea Unguium) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. J&J Latest Developments
Table 71. Chengdu Brilliant Details, Company Type, Onychomycosis (Tinea Unguium) Drug Area Served and Its Competitors
Table 72. Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Product Offered
Table 73. Chengdu Brilliant Main Business
Table 74. Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Chengdu Brilliant Latest Developments
Table 76. Novartis Details, Company Type, Onychomycosis (Tinea Unguium) Drug Area Served and Its Competitors
Table 77. Novartis Onychomycosis (Tinea Unguium) Drug Product Offered
Table 78. Novartis Main Business
Table 79. Novartis Onychomycosis (Tinea Unguium) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Novartis Latest Developments
Table 81. Qilu Pharmaceutical Details, Company Type, Onychomycosis (Tinea Unguium) Drug Area Served and Its Competitors
Table 82. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Offered
Table 83. Qilu Pharmaceutical Main Business
Table 84. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Qilu Pharmaceutical Latest Developments
Table 86. Xiuzheng Pharmaceutical Details, Company Type, Onychomycosis (Tinea Unguium) Drug Area Served and Its Competitors
Table 87. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Offered
Table 88. Xiuzheng Pharmaceutical Main Business
Table 89. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Xiuzheng Pharmaceutical Latest Developments
Table 91. Hubei Hengan Details, Company Type, Onychomycosis (Tinea Unguium) Drug Area Served and Its Competitors
Table 92. Hubei Hengan Onychomycosis (Tinea Unguium) Drug Product Offered
Table 93. Hubei Hengan Main Business
Table 94. Hubei Hengan Onychomycosis (Tinea Unguium) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Hubei Hengan Latest Developments
Table 96. TARO Details, Company Type, Onychomycosis (Tinea Unguium) Drug Area Served and Its Competitors
Table 97. TARO Onychomycosis (Tinea Unguium) Drug Product Offered
Table 98. TARO Main Business
Table 99. TARO Onychomycosis (Tinea Unguium) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. TARO Latest Developments
Table 101. Perrigo Details, Company Type, Onychomycosis (Tinea Unguium) Drug Area Served and Its Competitors
Table 102. Perrigo Onychomycosis (Tinea Unguium) Drug Product Offered
Table 103. Perrigo Onychomycosis (Tinea Unguium) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Perrigo Main Business
Table 105. Perrigo Latest Developments
Table 106. Galderma pharm Details, Company Type, Onychomycosis (Tinea Unguium) Drug Area Served and Its Competitors
Table 107. Galderma pharm Onychomycosis (Tinea Unguium) Drug Product Offered
Table 108. Galderma pharm Main Business
Table 109. Galderma pharm Onychomycosis (Tinea Unguium) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. Galderma pharm Latest Developments
Table 111. Zhejiang Deyer Details, Company Type, Onychomycosis (Tinea Unguium) Drug Area Served and Its Competitors
Table 112. Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Product Offered
Table 113. Zhejiang Deyer Main Business
Table 114. Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Zhejiang Deyer Latest Developments
Table 116. Valeant Pharma Details, Company Type, Onychomycosis (Tinea Unguium) Drug Area Served and Its Competitors
Table 117. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product Offered
Table 118. Valeant Pharma Main Business
Table 119. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. Valeant Pharma Latest Developments
Table 121. Moberg Details, Company Type, Onychomycosis (Tinea Unguium) Drug Area Served and Its Competitors
Table 122. Moberg Onychomycosis (Tinea Unguium) Drug Product Offered
Table 123. Moberg Main Business
Table 124. Moberg Onychomycosis (Tinea Unguium) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 125. Moberg Latest Developments
List of Figures
Figure 1. Onychomycosis (Tinea Unguium) Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Type in 2021
Figure 7. Onychomycosis (Tinea Unguium) Drug in Age under 18
Figure 8. Global Onychomycosis (Tinea Unguium) Drug Market: Age under 18 (2017-2022) & ($ Millions)
Figure 9. Onychomycosis (Tinea Unguium) Drug in Age 18-50
Figure 10. Global Onychomycosis (Tinea Unguium) Drug Market: Age 18-50 (2017-2022) & ($ Millions)
Figure 11. Onychomycosis (Tinea Unguium) Drug in Age above 50
Figure 12. Global Onychomycosis (Tinea Unguium) Drug Market: Age above 50 (2017-2022) & ($ Millions)
Figure 13. Global Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Application in 2021
Figure 14. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Player in 2021
Figure 15. Global Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Onychomycosis (Tinea Unguium) Drug Market Size 2017-2022 ($ Millions)
Figure 17. APAC Onychomycosis (Tinea Unguium) Drug Market Size 2017-2022 ($ Millions)
Figure 18. Europe Onychomycosis (Tinea Unguium) Drug Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size 2017-2022 ($ Millions)
Figure 20. Americas Onychomycosis (Tinea Unguium) Drug Value Market Share by Country in 2021
Figure 21. Americas Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Type in 2021
Figure 22. Americas Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Application in 2021
Figure 23. United States Onychomycosis (Tinea Unguium) Drug Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Onychomycosis (Tinea Unguium) Drug Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Onychomycosis (Tinea Unguium) Drug Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Onychomycosis (Tinea Unguium) Drug Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Region in 2021
Figure 28. APAC Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Application in 2021
Figure 29. China Onychomycosis (Tinea Unguium) Drug Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Onychomycosis (Tinea Unguium) Drug Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Onychomycosis (Tinea Unguium) Drug Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Onychomycosis (Tinea Unguium) Drug Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Onychomycosis (Tinea Unguium) Drug Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Onychomycosis (Tinea Unguium) Drug Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Country in 2021
Figure 36. Europe Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Type in 2021
Figure 37. Europe Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Application in 2021
Figure 38. Germany Onychomycosis (Tinea Unguium) Drug Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Onychomycosis (Tinea Unguium) Drug Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Onychomycosis (Tinea Unguium) Drug Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Onychomycosis (Tinea Unguium) Drug Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Onychomycosis (Tinea Unguium) Drug Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Application in 2021
Figure 46. Egypt Onychomycosis (Tinea Unguium) Drug Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Onychomycosis (Tinea Unguium) Drug Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Onychomycosis (Tinea Unguium) Drug Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Onychomycosis (Tinea Unguium) Drug Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Onychomycosis (Tinea Unguium) Drug Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Onychomycosis (Tinea Unguium) Drug Market Size 2023-2028 ($ Millions)
Figure 52. APAC Onychomycosis (Tinea Unguium) Drug Market Size 2023-2028 ($ Millions)
Figure 53. Europe Onychomycosis (Tinea Unguium) Drug Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size 2023-2028 ($ Millions)
Figure 55. United States Onychomycosis (Tinea Unguium) Drug Market Size 2023-2028 ($ Millions)
Figure 56. Canada Onychomycosis (Tinea Unguium) Drug Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Onychomycosis (Tinea Unguium) Drug Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Onychomycosis (Tinea Unguium) Drug Market Size 2023-2028 ($ Millions)
Figure 59. China Onychomycosis (Tinea Unguium) Drug Market Size 2023-2028 ($ Millions)
Figure 60. Japan Onychomycosis (Tinea Unguium) Drug Market Size 2023-2028 ($ Millions)
Figure 61. Korea Onychomycosis (Tinea Unguium) Drug Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Onychomycosis (Tinea Unguium) Drug Market Size 2023-2028 ($ Millions)
Figure 63. India Onychomycosis (Tinea Unguium) Drug Market Size 2023-2028 ($ Millions)
Figure 64. Australia Onychomycosis (Tinea Unguium) Drug Market Size 2023-2028 ($ Millions)
Figure 65. Germany Onychomycosis (Tinea Unguium) Drug Market Size 2023-2028 ($ Millions)
Figure 66. France Onychomycosis (Tinea Unguium) Drug Market Size 2023-2028 ($ Millions)
Figure 67. UK Onychomycosis (Tinea Unguium) Drug Market Size 2023-2028 ($ Millions)
Figure 68. Italy Onychomycosis (Tinea Unguium) Drug Market Size 2023-2028 ($ Millions)
Figure 69. Russia Onychomycosis (Tinea Unguium) Drug Market Size 2023-2028 ($ Millions)
Figure 70. Spain Onychomycosis (Tinea Unguium) Drug Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Onychomycosis (Tinea Unguium) Drug Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Onychomycosis (Tinea Unguium) Drug Market Size 2023-2028 ($ Millions)
Figure 73. Israel Onychomycosis (Tinea Unguium) Drug Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Onychomycosis (Tinea Unguium) Drug Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Onychomycosis (Tinea Unguium) Drug Market Size 2023-2028 ($ Millions)
Please feel free to write an email to us or to use our electronic ticketing system.
